Answers are grounded in this paper and cite their sources.
Shows improved treatment outcomes in schizophrenia, highlighting the potential of pharmacogenomic guidance.
Our findings demonstrate that CPGx significantly improves treatment outcomes in hospitalized patients with schizophrenia, supporting that CPGx can guide treatment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: